Spread | 0.06 | ||||
Long position overnight fee Long position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | -0.026179% | ||||
Short position overnight fee Short position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | 0.003957% | ||||
Overnight fee time | 21:00 (UTC) | ||||
Currency | USD | ||||
Min traded quantity | 1 | ||||
Margin | 20 | ||||
Stock exchange | United States of America | ||||
Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
Prev. Close | 0.68 |
Open | 0.73 |
1-Year Change | -7.59% |
Day's Range | 0.65 - 0.73 |
Vaxart Inc. is a clinical-stage biotechnology company headquartered in San Francisco, California. It works on the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. It also has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company’s proprietary oral vaccine platform for the Janssen universal influenza vaccine program.
Vaxart is traded on the Nasdaq under the ticker VXRT. In its finance for Q4 2021, the company reported revenue totalling $0.89m, a 77.9% decrease from the $4.04m result in 2020.